LaMoia TE, Butrico GM, Kalpage HA, et al
Headache rates in SURPASS trials Across the SURPASS clinical trials, between 4% and 14% of participants reported headaches depending on the dose they received
The Science Behind GLP-1 Peptides Therapeutic GLP-1 peptides, such as those found in medications like Semaglutide and Tirzepatide, are designed to bind to GLP-1 receptors throughout your body
Ozempic, which contains the active ingredient of GLP-1, functions by enhancing the bodys natural ability to produce insulin in response to increased blood sugar levels
There is no specific warning about drinking alcohol with Saxenda
Caudal Brainstem Processing is Sufficient for Behavioral, Sympathetic, and Parasympathetic Responses Driven by Peripheral and Hindbrain Glucagon-Like-Peptide-1 Receptor Stimulation